BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zhong YS, Lin N, Deng MH, Zhang FC, Tang ZF, Xu RY. Deficient proliferation of bone marrow-derived mesenchymal stem cells in patients with chronic hepatitis B viral infections and cirrhosis of the liver. Dig Dis Sci. 2010;55:438-445. [PMID: 19242797 DOI: 10.1007/s10620-009-0733-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Harrell CR, Popovska Jovicic B, Djonov V, Volarevic V. Molecular Mechanisms Responsible for Mesenchymal Stem Cell-Based Treatment of Viral Diseases. Pathogens 2021;10:409. [PMID: 33915728 DOI: 10.3390/pathogens10040409] [Reference Citation Analysis]
2 Zhong Y, Xu J, Deng M, Liu B, Zhang F, Yuan Y, Yang X, Xu R. Generation of a human bone marrow-derived mesenchymal stem cell line expressing and secreting high levels of bioactive  -melanocyte-stimulating hormone. Journal of Biochemistry 2013;153:371-9. [DOI: 10.1093/jb/mvt003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
3 Shetty R, Murugeswari P, Chakrabarty K, Jayadev C, Matalia H, Ghosh A, Das D. Stem cell therapy in coronavirus disease 2019: current evidence and future potential. Cytotherapy 2021;23:471-82. [PMID: 33257213 DOI: 10.1016/j.jcyt.2020.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Shi M, Zhang Z, Xu R, Lin H, Fu J, Zou Z, Zhang A, Shi J, Chen L, Lv S, He W, Geng H, Jin L, Liu Z, Wang FS. Human mesenchymal stem cell transfusion is safe and improves liver function in acute-on-chronic liver failure patients. Stem Cells Transl Med. 2012;1:725-731. [PMID: 23197664 DOI: 10.5966/sctm.2012-0034] [Cited by in Crossref: 189] [Cited by in F6Publishing: 175] [Article Influence: 18.9] [Reference Citation Analysis]
5 Huang KC, Chuang MH, Lin ZS, Lin YC, Chen CH, Chang CL, Huang PC, Syu WS, Chiou TW, Hong ZH, Tsai YC, Harn HJ, Lin PC, Lin SZ. Transplantation with GXHPC1 for Liver Cirrhosis: Phase 1 Trial. Cell Transplant 2019;28:100S-11S. [PMID: 31722556 DOI: 10.1177/0963689719884885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
6 Thanunchai M, Hongeng S, Thitithanyanont A. Mesenchymal Stromal Cells and Viral Infection. Stem Cells Int. 2015;2015:860950. [PMID: 26294919 DOI: 10.1155/2015/860950] [Cited by in Crossref: 39] [Cited by in F6Publishing: 33] [Article Influence: 5.6] [Reference Citation Analysis]
7 Zhong Y, Tang Z, Xu R, Lin N, Deng M, Fang H, Lin J, Zhu K, Liu Y, Kang Z. Effect of transplantation route on stem cell migration to fibrotic liver of rats via cellular magnetic resonance imaging. Cytotherapy 2013;15:1266-74. [PMID: 23993301 DOI: 10.1016/j.jcyt.2013.05.023] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
8 Rockel JS, Rabani R, Viswanathan S. Anti-fibrotic mechanisms of exogenously-expanded mesenchymal stromal cells for fibrotic diseases. Semin Cell Dev Biol 2020;101:87-103. [PMID: 31757583 DOI: 10.1016/j.semcdb.2019.10.014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
9 Lin N, Yao Z, Xu L, Xu M, Yuan L, Zhuang H, Lin Y, Xu R. Bone marrow-derived mesenchymal stem cells utilize the notch signaling pathway to induce apoptosis of hepatic stellate cells via NF-κB sensor. Biol Chem 2020;401:505-15. [PMID: 31527287 DOI: 10.1515/hsz-2019-0248] [Reference Citation Analysis]
10 Lin PC, Chiou TW, Lin ZS, Huang KC, Lin YC, Huang PC, Syu WS, Harn HJ, Lin SZ. A proposed novel stem cell therapy protocol for liver cirrhosis. Cell Transplant 2015;24:533-40. [PMID: 25671337 DOI: 10.3727/096368915X687228] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Fu N, Yang XF, Hu Y, Wu Q, Peng F. Efficacy of autologous bone marrow stem cell transplantation via the hepatic artery in combination with octreotide in the management of refractory ascites in patients with hepatic cirrhosis. Shijie Huaren Xiaohua Zazhi 2011; 19(22): 2376-2380 [DOI: 10.11569/wcjd.v19.i22.2376] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Wang Y, Wang F, Zhao H, Zhang X, Chen H, Zhang K. Human adipose-derived mesenchymal stem cells are resistant to HBV infection during differentiation into hepatocytes in vitro. Int J Mol Sci 2014;15:6096-110. [PMID: 24727377 DOI: 10.3390/ijms15046096] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
13 Zhang Z, Lin H, Shi M, Xu R, Fu J, Lv J, Chen L, Lv S, Li Y, Yu S, Geng H, Jin L, Lau GK, Wang FS. Human umbilical cord mesenchymal stem cells improve liver function and ascites in decompensated liver cirrhosis patients. J Gastroenterol Hepatol. 2012;27 Suppl 2:112-120. [PMID: 22320928 DOI: 10.1111/j.1440-1746.2011.07024.x] [Cited by in Crossref: 197] [Cited by in F6Publishing: 179] [Article Influence: 19.7] [Reference Citation Analysis]
14 Fu N, Yang XF, Wu Q, Liu ZX, Hu Y, Peng F. Treatment of different types of cirrhosis by autologous bone marrow stem cell transplantation via the hepatic artery: an analysis of 12 cases. Shijie Huaren Xiaohua Zazhi 2010; 18(21): 2274-2278 [DOI: 10.11569/wcjd.v18.i21.2274] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
15 Shi M, Liu Z, Wang Y, Xu R, Sun Y, Zhang M, Yu X, Wang H, Meng L, Su H, Jin L, Wang FS. A Pilot Study of Mesenchymal Stem Cell Therapy for Acute Liver Allograft Rejection. Stem Cells Transl Med. 2017;6:2053-2061. [PMID: 29178564 DOI: 10.1002/sctm.17-0134] [Cited by in Crossref: 42] [Cited by in F6Publishing: 45] [Article Influence: 14.0] [Reference Citation Analysis]
16 Li T, Xia M, Gao Y, Chen Y, Xu Y. Human umbilical cord mesenchymal stem cells: an overview of their potential in cell-based therapy. Expert Opin Biol Ther. 2015;15:1293-1306. [PMID: 26067213 DOI: 10.1517/14712598.2015.1051528] [Cited by in Crossref: 65] [Cited by in F6Publishing: 64] [Article Influence: 9.3] [Reference Citation Analysis]
17 Dong S, Su SB. Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis. J Integr Med. 2014;12:147-155. [PMID: 24861835 DOI: 10.1016/s2095-4964(14)60022-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
18 Yuan Y, Zhou C, Chen X, Tao C, Cheng H, Lu X. Suppression of tumor cell proliferation and migration by human umbilical cord mesenchymal stem cells: A possible role for apoptosis and Wnt signaling. Oncol Lett. 2018;15:8536-8544. [PMID: 29805590 DOI: 10.3892/ol.2018.8368] [Cited by in Crossref: 8] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
19 Riham Rabie I, Ahmad Mohamed S, Mostafa Mohamed S. Stem cell therapy in children with acute liver failure: The dream could come true. Ann Clin Gastroenterol Hepatol 2021;5:001-4. [DOI: 10.29328/journal.acgh.1001024] [Reference Citation Analysis]
20 Zhou X, Cui L, Zhou X, Yang Q, Wang L, Guo G, Hou Y, Cai W, Han Z, Shi Y, Han Y. Induction of hepatocyte-like cells from human umbilical cord-derived mesenchymal stem cells by defined microRNAs. J Cell Mol Med. 2017;21:881-893. [PMID: 27874233 DOI: 10.1111/jcmm.13027] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
21 Sasikala M, Surya P, Radhika G, Kumar PP, Rao MS, Mukherjee RM, Rao PN, Reddy DN. Identification of circulating CD90+ CD73+ cells in cirrhosis of liver. World J Stem Cells 2011; 3(7): 63-69 [PMID: 21860671 DOI: 10.4252/wjsc.v3.i7.63] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
22 Mezey É, Nemeth K. Mesenchymal stem cells and infectious diseases: Smarter than drugs. Immunology Letters 2015;168:208-14. [DOI: 10.1016/j.imlet.2015.05.020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 6.0] [Reference Citation Analysis]